Explaining America’s weirdly complicated food inspection system, including who regulates poultry and eggs and how Robert F.
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.
Driver on probation arrested after high-speed pursuit in Visalia. Drugs, loaded handgun, and evidence of drug sales found in ...
The Food and Drug Administration just raised its recall of Lay’s Classic Potato Chips to the highest risk level. On Dec. 16, Frito-Lay issued a recall for 6,344 (13-ounce) bags of Lay’s ...
The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...
Typically, funding for treatment can be difficult to come by, with only 600 “orphan” drugs approved for use by the US Food and Drug Administration (FDA). 1 The term’s origin can be found in ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
On Jan. 20, Dr. Robert M. Califf bid farewell to his role as Commissioner of the U.S. Food and Drug Administration in a reflective post on X, formerly Twitter, highlighting the agency’s progress ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
They acknowledge the need for more testing to confirm drug safety and efficacy, but they suggest if these results translate to human patients, ErSO-TFPy could be transformative for ER+ breast ...